|Bid||5.68 x 0|
|Ask||5.69 x 0|
|Day's Range||5.60 - 5.87|
|52 Week Range||2.65 - 10.05|
|Beta (5Y Monthly)||2.06|
|PE Ratio (TTM)||48.97|
|Earnings Date||Jul. 30, 2020 - Aug. 04, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.19|
Here's why you can look to buy Aphria Inc (TSX:APHA)(NASDAQ:APHA) stock instead of Canopy Growth (TSX:WEED)(NYSE:CGC) stock.The post Buy This 1 Weed Stock Instead of Canopy Growth (TSX:WEED) Stock appeared first on The Motley Fool Canada.
As a result of the COVID-19 pandemic, marijuana sales are skyrocketing as many people are turning to the product to deal with isolation, anxiety, and depression. Indeed, new market research compiled by Marijuana Business Factbook estimates medical and recreational cannabis sales are on track to grow by 40% this year over 2019, bringing total annual revenue to $15 billion by the end of 2020. Furthermore, the U.S. marijuana sector alone is estimated to be worth $37 billion by 2024 as more states join the legalization bandwagon.
LEAMINGTON, ON, July 6, 2020 /CNW/ - Aphria Inc. (" Aphria ") (TSX: APHA and NASDAQ: APHA), a leading global cannabis company, today announced that it has issued 1,658,375 common shares (the ...
Today, I'll look at two of the top pot stocks in the industry -- Aphria (NASDAQ: APHA) and Canopy Growth (NYSE: CGC) -- and assess which of these leading cannabis producers is the better stock to hold in your portfolio. One of the ways Aphria has established itself as one of the safer stocks in the industry is by being able to stay in the black on a relatively consistent basis. In its most recent quarterly results, which the company released on April 14, Aphria posted a net income of 5.7 million Canadian dollars on net revenue of CA$144.4 million.
Aphria Inc. (APHA) closed the most recent trading day at $4.29, making no change from the previous trading session.
A year from now, investors who buy shares of this bargain cannabis company will likely be rewarded for their courage.
Here's why cannabis investors should buy profitable stocks such as Aphria (TSX:APHA) and OrganiGram (TSX:OGI) right now. The post Ranking 3 Top Marijuana Stocks for 2020 appeared first on The Motley Fool Canada.
If you are looking to gain exposure to the marijuana space, look no further than Aphria (TSX:APHA) stock. The post Why Is Aphria (TSX:APHA) the Ultimate Pot Stock? appeared first on The Motley Fool Canada.
TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange:Toronto Stock Exchange (15,446.14, up 151.76 points.)Bombardier Inc. (TSX:BBD.B). Industrials. Down half a cent, or 1.12 per cent, to 44 cents on 12.1 million shares.Zenabis Global Inc. (TSX:ZENA). Health care. Down half a cent, or 5.88 per cent, to eight cents on 9.7 million shares.Suncor Energy Inc. (TSX:SU). Energy. Up five cents, or 0.22 per cent, to $22.80 on 7.8 million shares.Bonavista Energy Corp. (TSX:BNP). Energy. Up half a cent, or 9.09 per cent, to six cents on 7.9 million shares.Freegold Ventures Ltd. (TSX:FVL). Materials. Up 25 cents, or 28.74 per cent, to $1.12 on 7.7 million shares.Canadian Natural Resources Ltd. (TSX:CNQ). Energy. Up 19 cents, or 0.81 per cent, to $23.61 on 6.7 million shares.Companies in the news:Air Canada (TSX:AC). Down nine cents to $17.10. Air Canada has quietly changed its refund policy to allow some customers whose flights were cancelled due to the COVID-19 pandemic to recoup their cash — but not passengers whose trips originated in Canada. Customers with flights originating in the European Union, Switzerland and Iceland due to the pandemic are "entitled to receive a refund," states a document recently posted to Air Canada's website.Calfrac Well Services Ltd. (TSX:CFW). Down one cent or 5.6 per cent to 17 cents. Calfrac Well Services Ltd. is reporting a sharply deeper loss on lower revenue as demand for its oil and gas well completion services slumped in the first quarter. The Calgary-based company's net loss jumped to $123 million in the three months ended March 31 from a loss of $36 million in the year-earlier period. Revenue plunged 36 per cent to $305.5 million from $475 million in the same period of 2019.Canopy Growth Corp. (TSX:WEED). Down 15 cents to $22.62. Canopy Growth Corp. is shaking up its Acreage Holdings Inc. acquisition deal because of "broader market and economic factors." Smiths Falls, Ont.-based Canopy signed an agreement in April 2019 to take over the New York company if cannabis production and sale became federally legal in the United States. As part of the changes, which include an up-front payment for Acreage shareholders and certain convertible security holders totalling US$37.5 million or about 30 cents US per share, Acreage shareholders will receive 0.7 of a fixed share and 0.3 of a floating share for each Acreage share they hold.Aphria Inc. (TSX:APHA). Down seven cents or 1.2 per cent to $5.76. Aphria Inc. has reached a deal worth $29.1 million to settle a dispute with Emblem Cannabis Corp. and Aleafia Health Inc. The settlement ends a disagreement the companies had over Aleafia's decision in 2019 to cancel a supply agreement it had with Aphria. Aphria CEO Irwin Simon says the deal allows the companies to avoid the distraction and the potential expense of prolonged litigation. Under the agreement, Emblem, which was acquired by Aleafia in 2019, will receive $15 million in cash, $10 million in Aphria shares and a waiver of claimed receivables.This report by The Canadian Press was first published June 25, 2020.The Canadian Press
LEAMINGTON, ON, June 25, 2020 /CNW/ - Aphria Inc. ("Aphria") (TSX: APHA and NASDAQ: APHA), a leading global cannabis company, Emblem Cannabis Corporation ("Emblem"), and Aleafia Health Inc. (TSX: AH, OTC: ALEAF) ("Aleafia Health") today announced the parties entered into a settlement agreement on June 25, 2020 (the "Settlement Agreement") to resolve their outstanding dispute in respect of the termination of the parties' wholesale cannabis supply agreement (the "Supply Agreement"). Under the terms of the Settlement Agreement, Emblem shall receive total consideration of C$29,100,000 comprised of a C$15,500,000 cash payment, the issuance of common shares of Aphria with an aggregate market value of C$10,000,000 that will be freely tradeable and transferable in Canada and waiver of claimed receivables.
TSX cannabis stocks are up almost 50% in the last three months. Will the strength continue going forward? Or is weakness in the cards?The post How Top TSX Cannabis Stocks Are Placed for the Future appeared first on The Motley Fool Canada.
The green industry finally saw some green in the past few months. If it still has potential, which player should you bet on, Aphria or Aurora?The post Better Weed Stock: Aphria (TSX:APHA) vs. Aurora (TSX:ACB) appeared first on The Motley Fool Canada.
Today, we'll look at which of the two leading companies in the marijuana sector, Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY), is a better buy right now. During the first quarter of 2020, Tilray recognized $52.1 million in revenue, a rise of 126% year over year. Although that growth is spectacular, the company is not profitable -- it recorded a net loss of $184 million, largely due to non-cash adjustments to the fair value of its warrants.
In most places, the marijuana industry was deemed essential amid widespread lockdowns -- which is why revenue is pouring in for the sector. Then, there are Cronos Group (NASDAQ: CRON) and Aphria (NASDAQ: APHA), which are focused on staying afloat with their strong balance sheets. Its work on producing cannabinoids more cheaply and efficiently through biosynthesis with its partner Ginkgo Bioworks is impressive.